APA (7th ed.) Citation

Hasan, M. A., & Mukaddam, M. A. (2026). Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia. JCEM Case Reports, 4(6), 1. https://doi.org/10.1210/jcemcr/luag086

Chicago Style (17th ed.) Citation

Hasan, Marah Alsayed, and Mona Al Mukaddam. "Burosumab Use in Fibroblast Growth Factor-23-mediated Hypophosphatemia in McCune-Albright Syndrome/fibrous Dysplasia." JCEM Case Reports 4, no. 6 (2026): 1. https://doi.org/10.1210/jcemcr/luag086.

MLA (9th ed.) Citation

Hasan, Marah Alsayed, and Mona Al Mukaddam. "Burosumab Use in Fibroblast Growth Factor-23-mediated Hypophosphatemia in McCune-Albright Syndrome/fibrous Dysplasia." JCEM Case Reports, vol. 4, no. 6, 2026, p. 1, https://doi.org/10.1210/jcemcr/luag086.